10 recruiting. 10 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 10 | Recruiting 10 |
| Phase 2 | 3 | Recruiting 3 |
Follow Mycoses: new trials by email Literature Review of Mycoses trials Research Report on Mycoses
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Assess Efficacy, Safety and Tolerability of a Nail Patch in Patients With Nail Fragility, Mychosis, Psoriasis Cosmetic patch containing urea applicated daily for 3 months, Placebo patch application - Nail Psoriasis, Nail Damage | Phase 3 | Recruiting | Wooshin Labottach Co., Ltd. | 72 | 2026-02-01 | 2026-01-26 |
| Low Dose Trimethoprim-Sulfamethoxazole for the Treatment of Pneumocystis Jirovecii Pneumonia trimethoprim-sulfamethoxazole - Pneumocystis, Pneumocystis Pneumonia | Phase 3 | Recruiting | Todd C. Lee MD MPH FIDSA | 416 | 2025-11-28 | 2026-02-20 |
| A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Patients With Invasive Mold Infections. Fosmanogepix IV infusion, Standard of care antifungal therapy, Fosmanogepix oral tablet - Invasive Mold Infections | Phase 3 | Recruiting | Basilea Pharmaceutica | 234 | 2025-08-26 | 2026-10-28 |
| Platform Trial For Cryptococcal Meningitis (PLATFORM-CM) Standard of care, Oteseconazole - antifungal therapy 1, Turletricin injection - antifungal therapy 2 - Hiv, Cryptococcal Meningitis | Phase 2 / Phase 3 | Recruiting | David Boulware | 2000 | 2025-05-28 | 2026-07-27 |
| Efficacy and Safety of High-dose Liposomal Amphotericin B for Disseminated Histoplasmosis in AIDS Single high dose of liposomal amphotericin B, L-AmB standard dose - Disseminated Histoplasma Capsulatum Infection, AIDS and Infections | Phase 3 | Recruiting | Federal University of Health Science of Porto Alegre | 279 | 2025-01-16 | 2026-07-27 |
| A Phase 3 Efficacy and Safety Study of Fosmanogepix for the Treatment of Adult Participants With Candidemia and/or Invasive Candidiasis. Fosmanogepix, Caspofungin, Fluconazole - Candidemia, Candidiasis, Invasive | Phase 3 | Recruiting | Basilea Pharmaceutica | 450 | 2024-12-11 | 2026-10-19 |
| Efficacy and Safety of Clotrimazole+Lactulose Vaginal Suppositories Vs. Clotrimazole Monotherapy in Adult Women with Candidal Vaginitis/Vulvovaginitis Clotrimazole+Lactulose., Canesten (Clotrimazole), Lactulose - Candidal Vulvovaginitis (ICD-10 Code: B37.3), Vulvovaginal Candidiasis (VVC) | Phase 2 / Phase 3 | Recruiting | AVVA Pharmaceuticals Ltd. | 264 | 2024-02-29 | 2025-02-19 |
| A Randomized Trial of Prednisolone, Itraconazole, or Their Combination in Allergic Bronchopulmonary Aspergillosis Prednisolone, Itraconazole - Allergic Bronchopulmonary Aspergillosis | Phase 3 | Recruiting | Post Graduate Institute of Medical Education and Research, Chandigarh | 300 | 2023-12-01 | 2025-02-28 |
| The Effect of Medical Grade Honey Formulation (L-Mesitran) Administration on Recurrent Vulvovaginal Candidiasis Symptoms Fluconazole, L-Mesitran - Candidiasis, Vulvovaginal, Recurrent Candidiasis of Vagina | Phase 3 | Recruiting | Maastricht University Medical Center | 252 | 2022-08-22 | 2023-05-17 |
| Single Dose Liposomal Amphotericin for Asymptomatic Cryptococcal Antigenemia Single dose liposomal Amphotericin and Fluconazole, Fluconazole - Cryptococcal Meningitis | Phase 2 / Phase 3 | Recruiting | Makerere University | 356 | 2019-06-20 | 2026-04-28 |
Acquired Immunodeficiency Syndrome (2) · Candidiasis, Vulvovaginal (2) · Infections (2) · Meningitis, Cryptococcal (2) · Aspergillosis, Allergic Bronchopulmonary (1) · Candidemia (1) · Candidiasis, Invasive (1) · Histoplasmosis (1) · Pneumocystis Infections (1) · Pneumonia (1) · Pneumonia, Pneumocystis (1) · Psoriasis (1) · Torulopsis (1)
Bacterial Infections and Mycoses (10) · Infections (8) · Genital Diseases (4) · Urogenital Diseases (4) · Candidiasis (3) · Immune System Diseases (3) · Blood-Borne Infections (2) · Central Nervous System Diseases (2) · Central Nervous System Fungal Infections (2) · Central Nervous System Infections (2) · Communicable Diseases (2) · Cryptococcosis (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2)
Fluconazole (3) · liposomal amphotericin B (2) · Amphotericin B (1) · Caspofungin (1) · Clotrimazole (1) · Itraconazole (1) · Lactulose (1) · Off-Label Use (1) · Prednisolone (1) · Single Person (1) · Standard of Care (1) · Trimethoprim, Sulfamethoxazole Drug Combination (1)
Basilea Pharmaceutica (2) · AVVA Pharmaceuticals Ltd. (1) · David Boulware (1) · Federal University of Health Science of Porto Alegre (1) · Maastricht University Medical Center (1) · Makerere University (1) · Post Graduate Institute of Medical Education and Research, Chandigarh (1) · Todd C. Lee MD MPH FIDSA (1) · Wooshin Labottach Co., Ltd. (1)
Brazil (3) · Italy (3) · Australia (2) · Austria (2) · Belgium (2) · Canada (2) · France (2) · Germany (2) · Greece (2) · Israel (2) · Netherlands (2) · Spain (2) · Taiwan (2) · Thailand (2) · Uganda (2)
Alexandra Hill, MD (1) · Alison Kuchta, MD (1) · Daiane F Dalla Lana, PhD (1) · David B Meya, MBChB, MMed, PhD (1) · David R Boulware, MD, MPH (1) · Emily G McDonald, MD MSc (1) · Luana C Genz Bazana, PhD (1) · Renata B Ascenco Soares, PhD (1) · Tarsila Vieceli, MD MSc (1) · Todd C Lee, MD MPH FIDSA (1)